Subclinical decrease in cardiac autonomic and diastolic function in patients with metabolic disorders: HSCAA study.

Adiposity Cardiac diastolic dysfunction Diabetes Glucose tolerance Heart rate variability Insulin resistance Parasympathetic activity Visceral obesity

Journal

Metabolism open
ISSN: 2589-9368
Titre abrégé: Metabol Open
Pays: England
ID NLM: 101767753

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 28 12 2019
revised: 17 01 2020
accepted: 17 01 2020
entrez: 20 8 2020
pubmed: 20 8 2020
medline: 20 8 2020
Statut: epublish

Résumé

Heart failure due to decreased diastolic function, HFpEF, is a growing health concern with rising prevalence. We examined subclinical cardiac autonomic and diastolic functions in 605 patients with metabolic diseases classified as pre-heart failure. Presence of glucose intolerance or diabetes, or visceral adiposity was significantly associated with reduced cardiac autonomic and diastolic functions. Higher autonomic functions were significantly associated with a parameter of better cardiac diastolic function (E/A) (SDNN: r = 0.306, p < 0.01; HF: r = 0.341, p < 0.01), with the association independent of diabetes, body mass index, visceral adiposity and insulin resistance index. Thus, reduced autonomic function may be a potential predictor for decreased cardiac diastolic functions in metabolic disorders.

Identifiants

pubmed: 32812948
doi: 10.1016/j.metop.2020.100025
pii: S2589-9368(20)30005-0
pii: 100025
pmc: PMC7424828
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100025

Informations de copyright

© 2020 The Authors.

Déclaration de conflit d'intérêts

None of the authors have conflicts of interest to declare.

Références

Atherosclerosis. 2015 Feb;238(2):409-14
pubmed: 25558036
Cardiovasc Diabetol. 2010 Oct 15;9:63
pubmed: 20950415
N Engl J Med. 1988 Apr 28;318(17):1077-83
pubmed: 3352710
J Card Fail. 2014 Jan;20(1):53-9
pubmed: 24291683
Am J Cardiol. 2019 Jan 15;123(2):341-347
pubmed: 30420185
Circ Res. 2014 Apr 25;114(9):1500-15
pubmed: 24763467
Eur J Heart Fail. 2018 May;20(5):853-872
pubmed: 29520964
Diabetes Care. 2004 Jan;27 Suppl 1:S5-S10
pubmed: 14693921
Metabolism. 2015 Dec;64(12):1704-14
pubmed: 26454717
Diabetologia. 2005 Feb;48(2):394-402
pubmed: 15645206
Am J Cardiol. 2018 Jun 15;121(12):1552-1557
pubmed: 29627106
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
J Atheroscler Thromb. 2013;20(6):517-23
pubmed: 23665881
N Engl J Med. 2006 Jul 20;355(3):251-9
pubmed: 16855265
Circulation. 2011 May 10;123(18):2006-13; discussion 2014
pubmed: 21555723
Metabolism. 2003 Jul;52(7):815-20
pubmed: 12870154
JACC Heart Fail. 2018 Dec;6(12):999-1007
pubmed: 30316935
Diabetologia. 2010 Jul;53(7):1331-40
pubmed: 20386878
Cardiovasc Diabetol. 2015 Sep 04;14:117
pubmed: 26338087
Eur Heart J. 1996 Mar;17(3):354-81
pubmed: 8737210
PLoS One. 2014 Aug 25;9(8):e105977
pubmed: 25153796
J Clin Endocrinol Metab. 2017 Oct 1;102(10):3756-3764
pubmed: 28973588
Atherosclerosis. 2018 Mar;270:95-101
pubmed: 29407894
JACC Heart Fail. 2018 Apr;6(4):317-325
pubmed: 29525334
Circ Res. 2014 Jun 20;115(1):79-96
pubmed: 24951759
Metabolism. 2012 Sep;61(9):1270-9
pubmed: 22444779
Metabolism. 2011 Aug;60(8):1115-21
pubmed: 21306747
Trends Cardiovasc Med. 2006 Nov;16(8):273-9
pubmed: 17055383
J Am Coll Cardiol. 2009 Jul 28;54(5):375-85
pubmed: 19628111
Nat Rev Cardiol. 2017 Oct;14(10):591-602
pubmed: 28492288
Int J Cardiol. 2016 Oct 1;220:349-55
pubmed: 27390954
Circ Res. 2014 May 23;114(11):1815-26
pubmed: 24855204
Metabolism. 2019 Aug;97:18-24
pubmed: 31125536
J Am Coll Cardiol. 2019 Apr 23;73(15):1961-1977
pubmed: 31000000
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360
pubmed: 27422899
Clin Cardiol. 2019 Feb;42(2):305-311
pubmed: 30592058
J Am Coll Cardiol. 2014 Dec 2;64(21):2281-93
pubmed: 25456761
Circulation. 2009 Jun 23;119(24):3070-7
pubmed: 19506115
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
J Am Coll Cardiol. 1998 Sep;32(3):732-8
pubmed: 9741520
Diabetes Care. 2018 Apr;41(4):731-738
pubmed: 29317451

Auteurs

Akiko Morimoto (A)

Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.

Manabu Kadoya (M)

Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.

Miki Kakutani-Hatayama (M)

Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.

Kae Kosaka-Hamamoto (K)

Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.

Akio Miyoshi (A)

Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.

Takuhito Shoji (T)

Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.

Akiko Goda (A)

Division of Cardiovascular and Renal Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.

Masanori Asakura (M)

Division of Cardiovascular and Renal Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.

Hidenori Koyama (H)

Division of Diabetes, Endocrinology and Clinical Immunology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, 663-8501, Japan.

Classifications MeSH